AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 167 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $33,552,000 | +83.7% | 973,920 | -10.9% | 1.35% | +72.4% |
| Q2 2020 | $18,266,000 | +28.9% | 1,093,144 | +11.3% | 0.78% | -1.0% |
| Q1 2020 | $14,167,000 | -41.7% | 982,484 | +35.4% | 0.79% | -3.5% |
| Q4 2019 | $24,280,000 | +54.1% | 725,431 | -3.6% | 0.82% | +45.8% |
| Q3 2019 | $15,754,000 | +13.0% | 752,358 | +12.4% | 0.56% | +21.6% |
| Q2 2019 | $13,940,000 | +22.1% | 669,560 | +31.1% | 0.46% | +26.2% |
| Q1 2019 | $11,414,000 | – | 510,709 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |